Jessica Tassan
Stock Analyst at Piper Sandler
(0.91)
# 3,702
Out of 4,857 analysts
71
Total ratings
23.21%
Success rate
-11.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Overweight | $25 → $18 | $14.62 | +23.16% | 5 | Jun 9, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $552 → $353 | $302.74 | +16.60% | 6 | Jun 3, 2025 | |
| CTEV Claritev | Upgrades: Overweight | $19 → $44 | $39.09 | +12.56% | 2 | May 29, 2025 | |
| AMWL American Well | Reiterates: Neutral | $10 → $8 | $7.53 | +6.31% | 3 | May 23, 2025 | |
| PINC Premier | Maintains: Neutral | $19 → $24 | $22.89 | +4.85% | 6 | May 21, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $348 → $374 | $315.97 | +18.37% | 4 | May 5, 2025 | |
| CVS CVS Health | Maintains: Overweight | $72 → $74 | $64.46 | +14.80% | 5 | Mar 21, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $14 → $21 | $14.60 | +43.84% | 5 | Mar 4, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $13 → $12 | $7.45 | +61.07% | 6 | Feb 27, 2025 | |
| EVH Evolent Health | Reiterates: Overweight | $17 → $16 | $8.93 | +79.17% | 3 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $8 | $4.17 | +91.85% | 11 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $31 → $33 | $27.90 | +18.28% | 5 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $270 → $288 | $234.01 | +23.07% | 3 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $58.42 | -60.63% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $31.70 | +120.82% | 4 | Aug 2, 2023 |
Oscar Health
Jun 9, 2025
Maintains: Overweight
Price Target: $25 → $18
Current: $14.62
Upside: +23.16%
UnitedHealth Group
Jun 3, 2025
Maintains: Overweight
Price Target: $552 → $353
Current: $302.74
Upside: +16.60%
Claritev
May 29, 2025
Upgrades: Overweight
Price Target: $19 → $44
Current: $39.09
Upside: +12.56%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $7.53
Upside: +6.31%
Premier
May 21, 2025
Maintains: Neutral
Price Target: $19 → $24
Current: $22.89
Upside: +4.85%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $315.97
Upside: +18.37%
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $64.46
Upside: +14.80%
Alignment Healthcare
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $14.60
Upside: +43.84%
Teladoc Health
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.45
Upside: +61.07%
Evolent Health
Feb 21, 2025
Reiterates: Overweight
Price Target: $17 → $16
Current: $8.93
Upside: +79.17%
Feb 11, 2025
Maintains: Overweight
Price Target: $12 → $8
Current: $4.17
Upside: +91.85%
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $27.90
Upside: +18.28%
Jan 15, 2025
Maintains: Neutral
Price Target: $270 → $288
Current: $234.01
Upside: +23.07%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $58.42
Upside: -60.63%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $31.70
Upside: +120.82%